These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11858500)

  • 1. Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy.
    Hoffman R; Mahajana A; Agmon P; Baruch Y; Brenner B
    Thromb Haemost; 2002 Feb; 87(2):346-7. PubMed ID: 11858500
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe intra-abdominal bleeding post liver biopsy - failure to respond to recombinant Factor VII.
    Quinn JP; Murphy PT
    Thromb Haemost; 2004 Mar; 91(3):632-3. PubMed ID: 14983243
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
    Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
    [No Abstract]   [Full Text] [Related]  

  • 4. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
    Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant activated factor VII used in a man with refractory bleeding from a stab wound injuring the liver and kidney].
    Arnal D; Piñeiro P; Garutti I; Olmedilla L; Sanz J; Lajara A
    Rev Esp Anestesiol Reanim; 2004 May; 51(5):284-8. PubMed ID: 15214766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
    Holub Z; Feyereisl J; Kabelík L; Rittstein T
    Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?].
    Skalski JH; Czapla J; Nadziakiewicz P; Kaczmarski J; Zembala M
    Przegl Lek; 2002; 59(11):941-5. PubMed ID: 12715727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
    Martínez J; Cid AR; de la Rubia J; Gimeno R
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of a subcapsular renal bleeding after extracorporeal shockwave lithotripsy with recombinant, activated factor VII].
    Langer H; Strohmaier WL; Probst S
    Anaesthesist; 2002 Nov; 51(11):914-7. PubMed ID: 12434265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
    Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
    Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
    Lim Y; Loo CC; Chia V; Fun W
    Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor VII, a therapeutic alternative in the treatment of severe haemoghage disorders].
    Morales León V; Herrera Ortega G; Molero Gómez R; García Cortés J
    Farm Hosp; 2003; 27(1):38-41. PubMed ID: 12607015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
    Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
    Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding problems in the newborn infant.
    Chessells JM; Hardisty RM
    Prog Hemost Thromb; 1974; 2(0):333-61. PubMed ID: 4850793
    [No Abstract]   [Full Text] [Related]  

  • 16. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
    Tanchev S; Platikanov V; Karadimov D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
    [No Abstract]   [Full Text] [Related]  

  • 17. [New therapeutic possibilities for uncontrolled bleeding].
    Mikos B; Kiss K; Bolyos A; Ormay C
    Orv Hetil; 2004 Jan; 145(3):111-7. PubMed ID: 15027332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
    Pepas LP; Arif-Adib M; Kadir RA
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
    Hünseler C; Kribs A; Eifinger F; Roth B
    J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical review of bleeding dilemmas in trauma.
    Hoyt DB
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):40-3. PubMed ID: 14872420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.